Sarah Wustefeld’s Post

View profile for Sarah Wustefeld, graphic

Vice President of Growth @ DarioHealth | Enterprise Sales

💊 #GLP-1 ... know anyone taking them? 🏥 #Diabetes ... May 15, 2024 According to the National Diabetes Statistics Report — Prevalence of both diagnosed and undiagnosed diabetes · 38.4 million people of all ages—or 11.6% of the U.S. population. ⬆ Read that again ⬆ (yikes) We at DarioHealth also saw in a recent study that 81% of HR decision-makers feel that their employees would be interested in GLP-1 medications. But what does all this mean... ❓ Should companies pay for their employees to take these medications? ❓Should we put guardrails in place as to who should be taking them? ❓What's in it for all of us to take back America's health? I'm proud to be at DarioHealth as we help to navigate employees (oh wait PEOPLE) get their lives back. Check out our e-book on GLP-1s: https://lnkd.in/gm-ABM-Y

eBook: The Value of GLP-1s: Reality Check

eBook: The Value of GLP-1s: Reality Check

letstalk.dariohealth.com

To view or add a comment, sign in

Explore topics